Inventor · disambiguated record
Piotr Marek Swiderski
Also filed as: SWIDERSKI PIOTR · SWIDERSKI PIOTR M · SWIDERSKI PIOTR MAREK
22 granted patents·13 pending applications·120 citations·filing 1996–2025
94Inventor score
Top patents by PatentIndex Score
35 records- 0196US9976147B2STAT3 inhibitors and uses thereofHOPE CITY·Filed 2016·Granted May 22, 2018·13 cites·24 claims
- 0294US11591596B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2020·Granted Feb 28, 2023·3 cites·34 claims
- 0393US12227745B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2023·Granted Feb 18, 2025·1 cites·20 claims
- 0492US11912995B2CTLA-4 aptamer conjugatesHOPE CITY·Filed 2021·Granted Feb 27, 2024·1 cites·17 claims
- 0592US10801026B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2016·Granted Oct 13, 2020·6 cites·15 claims
- 0689US10758624B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2016·Granted Sep 1, 2020·5 cites·20 claims
- 0788US10967070B2Cell penetrating conjugates and methods of use thereofHOPE CITY·Filed 2016·Granted Apr 6, 2021·3 cites·8 claims
- 0888US9688982B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2013·Granted Jun 27, 2017·7 cites·4 claims
- 0987US11208654B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2019·Granted Dec 28, 2021·1 cites·16 claims
- 1087US8748405B2Methods and compositions for the treatment of cancer or other diseasesYU HUA·Filed 2011·Granted Jun 10, 2014·7 cites·3 claims
- 1186US10253318B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2017·Granted Apr 9, 2019·3 cites·14 claims
- 1284US9200280B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·4 cites·3 claims
- 1383US2024309379A1Ctla-4 aptamer conjugatesHOPE CITY·Filed 2024·Application pending·0 cites
- 1482US11464865B2Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2020·Granted Oct 11, 2022·1 cites·20 claims
- 1582US10829765B2STAT3 inhibitors and uses thereofHOPE CITY·Filed 2018·Granted Nov 10, 2020·1 cites·20 claims
- 1681US6379931B1Chimeric DNA/RNA ribozymes containing propanediolHOPE CITY·Filed 2000·Granted Apr 30, 2002·8 cites·7 claims
- 1781US5766550ADisposable reagent storage and delivery cartridgeHOPE CITY·Filed 1996·Granted Jun 16, 1998·54 cites·18 claims
- 1879US2023193258A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2021·Application pending·0 cites
- 1976US10538761B2Multivalent oligonucleotide assembliesHOPE CITY·Filed 2016·Granted Jan 21, 2020·1 cites·19 claims
- 2074US12138279B2Bi specific aptamerHOPE CITY·Filed 2021·Granted Nov 12, 2024·0 cites·23 claims
- 2174US9200279B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·1 cites·4 claims
- 2273US2022401563A1Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 2369US2025207135A1Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereofHOPE CITY·Filed 2025·Application pending·0 cites
- 2468US2021207142A1Stat3 inhibitors and uses thereofHOPE CITY·Filed 2020·Application pending·0 cites
- 2566US11535847B2Multivalent oligonucleotide assembliesHOPE CITY·Filed 2019·Granted Dec 27, 2022·0 cites·3 claims
- 2660US2023203085A1Multi-conjugates comprising multiple ligandsMPEG LA L L C·Filed 2022·Application pending·0 cites
- 2759US2008214436A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2007·Application pending·0 cites
- 2858US2025376689A1Oligonucleotides having 6-thio-2'-deoxyguanosine residues and uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 2956US12043673B2Complementary RNA linked bispecific T-cell engaging antibodiesHOPE CITY·Filed 2021·Granted Jul 23, 2024·0 cites·12 claims
- 3056US2023220385A1Microrna as a therapeutic agentHOPE CITY·Filed 2020·Application pending·0 cites
- 3155US12404509B2Oligonucleotide-based proteolysis targeting chimeraHOPE CITY·Filed 2019·Granted Sep 2, 2025·0 cites·20 claims
- 3253US2022002730A1Oligonucleotide inhibitors of nuclear factor kappa-light-chain-enhancer of activated b cells and the uses thereofHOPE CITY·Filed 2019·Application pending·0 cites
- 3349US2003228596A1Template-driven nucleic acid amplificationsFiled 2003·Application pending·0 cites
- 3441US2020181264A1Bispecific antigen-binding moleculeHOPE CITY·Filed 2018·Application pending·0 cites
- 3536US2011071210A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Piotr Marek Swiderski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →